Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC

NCT01993810 is registered in ClinicalTrials.gov with Radiation Therapy Oncology Group as lead sponsor.

NCT NCT01993810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01993810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC
Lead sponsor
Radiation Therapy Oncology Group
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 3, 2014
Completion date
November 30, 2028
Enrollment
330 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

stage ii non-small cell lung cancer ajcc v7, stage iia non-small cell lung carcinoma ajcc v7, stage iib non-small cell lung carcinoma ajcc v7, stage iii non-small cell lung cancer ajcc v7, stage iiia non-small cell lung cancer ajcc v7, stage iiib non-small cell lung cancer ajcc v7